BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33253788)

  • 21. Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma.
    Kang H; Lee S; Kim K; Jeon J; Kang SG; Youn H; Kim HY; Youn B
    J Exp Clin Cancer Res; 2021 Sep; 40(1):282. PubMed ID: 34488821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy-resistant tumor microvascular endothelial cells contribute to treatment failure in glioblastoma multiforme.
    Borovski T; Beke P; van Tellingen O; Rodermond HM; Verhoeff JJ; Lascano V; Daalhuisen JB; Medema JP; Sprick MR
    Oncogene; 2013 Mar; 32(12):1539-48. PubMed ID: 22614016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI.
    Yang YP; Chien Y; Chiou GY; Cherng JY; Wang ML; Lo WL; Chang YL; Huang PI; Chen YW; Shih YH; Chen MT; Chiou SH
    Biomaterials; 2012 Feb; 33(5):1462-76. PubMed ID: 22098779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusion.
    Hussein D; Punjaruk W; Storer LC; Shaw L; Othman R; Peet A; Miller S; Bandopadhyay G; Heath R; Kumari R; Bowman KJ; Braker P; Rahman R; Jones GD; Watson S; Lowe J; Kerr ID; Grundy RG; Coyle B
    Neuro Oncol; 2011 Jan; 13(1):70-83. PubMed ID: 20978004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting glioblastoma cancer stem cells: the next great hope?
    Khan IS; Ehtesham M
    Neurosurg Focus; 2014 Dec; 37(6):E7. PubMed ID: 25581936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
    Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH
    OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells.
    Bou-Gharios J; Assi S; Bahmad HF; Kharroubi H; Araji T; Chalhoub RM; Ballout F; Harati H; Fares Y; Abou-Kheir W
    Pharmacol Rep; 2021 Feb; 73(1):227-239. PubMed ID: 33140310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of Farnesyltransferase Potentiates NOTCH-Targeted Therapy against Glioblastoma Stem Cells.
    Ma Y; Cheng Z; Liu J; Torre-Healy L; Lathia JD; Nakano I; Guo Y; Thompson RC; Freeman ML; Wang J
    Stem Cell Reports; 2017 Dec; 9(6):1948-1960. PubMed ID: 29198824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma.
    Biserova K; Jakovlevs A; Uljanovs R; Strumfa I
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD44-associated radioresistance of glioblastoma in irradiated brain areas with optimal tumor coverage.
    Liu WH; Lin JC; Chou YC; Li MH; Tsai JT
    Cancer Med; 2020 Jan; 9(1):350-360. PubMed ID: 31746135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide.
    Kim SS; Harford JB; Moghe M; Rait A; Pirollo KF; Chang EH
    Nucleic Acids Res; 2018 Feb; 46(3):1424-1440. PubMed ID: 29202181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.
    Lee Y; Kim KH; Kim DG; Cho HJ; Kim Y; Rheey J; Shin K; Seo YJ; Choi YS; Lee JI; Lee J; Joo KM; Nam DH
    PLoS One; 2015; 10(10):e0137703. PubMed ID: 26444992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate.
    Chen Q; Wu J; Ye Q; Ma F; Zhu Q; Wu Y; Shan C; Xie X; Li D; Zhan X; Li C; Li XF; Qin X; Zhao T; Wu H; Shi PY; Man J; Qin CF
    mBio; 2018 Sep; 9(5):. PubMed ID: 30228241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GBM radiosensitizers: dead in the water…or just the beginning?
    Bindra RS; Chalmers AJ; Evans S; Dewhirst M
    J Neurooncol; 2017 Sep; 134(3):513-521. PubMed ID: 28762004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic pathways and glioblastoma treatment.
    Clarke J; Penas C; Pastori C; Komotar RJ; Bregy A; Shah AH; Wahlestedt C; Ayad NG
    Epigenetics; 2013 Aug; 8(8):785-95. PubMed ID: 23807265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of Enhancing Effects of Curcumin on Radiotherapy with F98/
    Wang WH; Shen CY; Chien YC; Chang WS; Tsai CW; Lin YH; Hwang JJ
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone chaperone FACT complex inhibitor CBL0137 interferes with DNA damage repair and enhances sensitivity of medulloblastoma to chemotherapy and radiation.
    Song H; Xi S; Chen Y; Pramanik S; Zeng J; Roychoudhury S; Harris H; Akbar A; Elhag SS; Coulter DW; Ray S; Bhakat KK
    Cancer Lett; 2021 Nov; 520():201-212. PubMed ID: 34271103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastoma.
    Yahyanejad S; King H; Iglesias VS; Granton PV; Barbeau LM; van Hoof SJ; Groot AJ; Habets R; Prickaerts J; Chalmers AJ; Eekers DB; Theys J; Short SC; Verhaegen F; Vooijs M
    Oncotarget; 2016 Jul; 7(27):41251-41264. PubMed ID: 27183910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.